IRONWOOD PHARMACEUTICALS INC (IRWD) insider trading

By person

33 insiders · 315 transactions

9.8×

Thomas McCourt holds 9.8 times base salary in stock. $8.58M of shares against $867.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas McCourt last reported holding, valued at $4.52, the price Class A Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Mark G Currie

Director

—

$17.72M (20) scheduled

−$17.72M

676,900

$3.06M

−4.7%

Thomas A MCCOURT

Chief Executive Officer

—

$14.80M (50)

−$14.80M

1,898,838

$8.58M

+4,034%

Peter M Hecht

Chief Executive Officer

—

$3.87M (7) scheduled

−$3.87M

2,231,916

$10.09M

−52.4%

Halley E Gilbert

Chief Admin Officer & SVP

—

$3.62M (24) scheduled

−$3.62M

265,991

$1.20M

+279.3%

Jason Rickard

SVP, Chief Operating Officer

—

$2.42M (28)

−$2.42M

376,316

$1.70M

+56.0%

Alexander J Denner

Director

$22.83M (8)

$20.53M (2)

+$2.30M

25,906,184

$117.10M

−13.5%

Michael Shetzline

SVP, CMO, Head-Res&Drug

—

$1.75M (21)

−$1.75M

1,179,462

$5.33M

+105.6%

Minardo John

Chief Legal Officer

—

$1.32M (11)

−$1.32M

500,498

$2.26M

—

Ronald Silver

PFO & PAO

—

$1.20M (21) scheduled

−$1.20M

755,250

$3.41M

+43.4%

Julie McHugh

Director

—

$827.16K (13)

−$827.16K

389,122

$1.76M

+89.7%

Gina Consylman

SVP, CFO & Treasurer

—

$639.35K (32)

−$639.35K

392,616

$1.77M

+1,759%

Mark Mallon

Chief Executive Officer

—

$612.48K (5)

−$612.48K

470,605

$2.13M

—

Lawrence S Olanoff

Director

—

$519.28K (13)

−$519.28K

91,395

$413.11K

+211.9%

Catherine Moukheibir

Director

—

$517.69K (2)

−$517.69K

181,425

$820.04K

—

Andrew Davis

SVP, Chief Business Officer

—

$493.29K (8)

−$493.29K

284,685

$1.29M

+75.2%

Kelly MacDonald

Chief Accounting Officer

—

$455.97K (17)

−$455.97K

93,041

$420.55K

+27.0%

Sravan Kumar Emany

SVP, COO and CFO

$400.33K (2)

$120.93K (2)

+$279.41K

309,572

$1.40M

—

Marla L Kessler

Director

—

$199.73K (2) scheduled

−$199.73K

229,364

$1.04M

—

Edward P Owens

Director

$137.07K (3)

—

+$137.07K

281,720

$1.27M

+68.0%

Gregory S. Martini

Chief Financial Officer

—

$104.16K (4)

−$104.16K

297,213

$1.34M

+250.7%

Tammi L Gaskins

Chief Commercial Officer

—

$102.89K (5)

−$102.89K

350,350

$1.58M

+42.9%

Conor Kilroy

SVP, GC & Secretary

—

$80.21K (8)

−$80.21K

122,336

$552.96K

+13.2%

Jon R Duane

Director

$60.20K (1)

—

+$60.20K

253,820

$1.15M

—

Thomas Graney

Chief Financial Officer

—

$31.75K (2)

−$31.75K

42,013

$189.90K

+85.6%

Christopher T Phd Walsh

Director

—

374,525

$1.69M

+0.1%

Jay Shepard

Director

—

235,036

$1.06M

—

Andrew Dreyfus

Director

—

228,313

$1.03M

—

Terrance McGuire

Director

—

145,999

$659.92K

+25.2%

Jeffrey Silber

SVP, CMO, Head-Res&Drug

—

137,036

$619.40K

—

Marsha Fanucci

Director

—

132,663

$599.64K

+26.5%

Douglas E Williams

Director

—

87,800

$396.86K

+46.3%

Amy W Schulman

Director

—

38,242

$172.85K

—

William Huyett

Chief Operating Officer

—

27,546

$124.51K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

IRONWOOD PHARMACEUTICALS INC

What the insiders did Net selling

By person